Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 940131, 8 pages
http://dx.doi.org/10.1155/2015/940131
Review Article

Oxidative Stress and Protein Quality Control Systems in the Aged Canine Brain as a Model for Human Neurodegenerative Disorders

Faculty of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy

Received 17 December 2014; Accepted 29 April 2015

Academic Editor: Javier Egea

Copyright © 2015 Mariarita Romanucci and Leonardo Della Salda. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Head, “A canine model of human aging and Alzheimer's disease,” Biochimica et Biophysica Acta, vol. 1832, no. 9, pp. 1384–1389, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. P. R. Davis and E. Head, “Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges,” Frontiers in Pharmacology, vol. 5, article 47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Borràs, I. Ferrer, M. Pumarola, and B. Murcia, “Age-related changes in the brain of the dog,” Veterinary Pathology, vol. 36, no. 3, pp. 202–211, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. M.-Y. Su, E. Head, W. M. Brooks et al., “Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging,” Neurobiology of Aging, vol. 19, no. 5, pp. 479–485, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. J. González-Soriano, P. M. García, J. Contreras-Rodríguez, P. Martínez-Sainz, and E. Rodríguez-Veiga, “Age-related changes in the ventricular system of the dog brain,” Annals of Anatomy, vol. 183, no. 3, pp. 283–291, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. C. T. Siwak-Tapp, E. Head, B. A. Muggenburg, N. W. Milgram, and C. W. Cotman, “Neurogenesis decreases with age in the canine hippocampus and correlates with cognitive function,” Neurobiology of Learning and Memory, vol. 88, no. 2, pp. 249–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Pekcec, W. Baumgärtner, J. P. Bankstahl, V. M. Stein, and H. Potschka, “Effect of aging on neurogenesis in the canine brain,” Aging Cell, vol. 7, no. 3, pp. 368–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Selkoe, D. S. Bell, M. B. Podlisny, D. L. Price, and L. C. Cork, “Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease,” Science, vol. 235, no. 4791, pp. 873–877, 1987. View at Publisher · View at Google Scholar · View at Scopus
  9. E. M. Johnstone, M. O. Chaney, F. H. Norris, R. Pascual, and S. P. Little, “Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis,” Molecular Brain Research, vol. 10, no. 4, pp. 299–305, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Wiśniewski, A. B. Johnson, C. S. Raine, W. J. Kay, and R. D. Terry, “Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study,” Laboratory Investigation, vol. 23, no. 3, pp. 287–296, 1970. View at Google Scholar · View at Scopus
  11. G. Giaccone, L. Verga, M. Finazzi et al., “Cerebral preamyloid deposits and congophilic angiopathy in aged dogs,” Neuroscience Letters, vol. 114, no. 2, pp. 178–183, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Ishihara, T. Gondo, M. Takahashi et al., “Immunohistochemical and immunoelectron microscopical characterization of cerebrovascular and senile plaque amyloid in aged dogs' brains,” Brain Research, vol. 548, no. 1-2, pp. 196–205, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Head, R. McCleary, F. F. Hahn, N. W. Milgram, and C. W. Cotman, “Region-specific age at onset of β-amyloid in dogs,” Neurobiology of Aging, vol. 21, no. 1, pp. 89–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Braak and E. Braak, “Neuropathological stageing of Alzheimer-related changes,” Acta Neuropathologica, vol. 82, no. 4, pp. 239–259, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Braak, E. Braak, and J. Bohl, “Staging of Alzheimer-related cortical destruction,” European Neurology, vol. 33, no. 6, pp. 403–408, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. D. R. Thal, U. Rüb, M. Orantes, and H. Braak, “Phases of Aβ-deposition in the human brain and its relevance for the development of AD,” Neurology, vol. 58, no. 12, pp. 1791–1800, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Satou, B. J. Cummings, E. Head et al., “The progression of β-amyloid deposition in the frontal cortex of the aged canine,” Brain Research, vol. 774, no. 1-2, pp. 35–43, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Y. Azizeh, E. Head, M. A. Ibrahim et al., “Molecular dating of senile plaques in the brains of individuals with down syndrome and in aged dogs,” Experimental Neurology, vol. 163, no. 1, pp. 111–122, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. B. J. Cummings, E. Head, A. J. Afagh, N. W. Milgram, and C. W. Cotman, “β-amyloid accumulation correlates with cognitive dysfunction in the aged canine,” Neurobiology of Learning and Memory, vol. 66, no. 1, pp. 11–23, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Head, H. Callahan, B. A. Muggenburg, C. W. Cotman, and N. W. Milgram, “Visual-discrimination learning ability and β-amyloid accumulation in the dog,” Neurobiology of Aging, vol. 19, no. 5, pp. 415–425, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. M.-A. Colle, J.-J. Hauw, F. Crespeau et al., “Vascular and parenchymal Aβ deposition in the aging dog: correlation with behavior,” Neurobiology of Aging, vol. 21, no. 5, pp. 695–704, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. J. E. Rofina, A. M. Van Ederen, M. J. M. Toussaint et al., “Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease,” Brain Research, vol. 1069, no. 1, pp. 216–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Uchida, Y. Tani, K. Uetsuka, H. Nakayama, and N. Goto, “Immunohistochemical studies on canine cerebral amyloid angiopathy and senile plaques,” The Journal of Veterinary Medical Science, vol. 54, no. 4, pp. 659–667, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. B. J. Cummings, J. H. Su, C. W. Cotman, R. White, and M. J. Russell, “β-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease,” Neurobiology of Aging, vol. 14, no. 6, pp. 547–560, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Morys, O. Narkiewicz, B. Maciejewska, J. Wegiel, and H. M. Wisniewski, “Amyloid deposits and loss of neurones in the claustrum of the aged dog,” NeuroReport, vol. 5, no. 14, pp. 1825–1828, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Torp, E. Head, N. W. Milgram, F. Hahn, O. P. Ottersen, and C. W. Cotman, “Ultrastructural evidence of fibrillar β-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains,” Neuroscience, vol. 96, no. 3, pp. 495–506, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. C. Morris, M. Storandt, D. W. McKeel Jr. et al., “Cerebral amyloid deposition and diffuse plaques in ‘normal’ aging: evidence for presymptomatic and very mild Alzheimer's disease,” Neurology, vol. 46, no. 3, pp. 707–719, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. W. R. Markesbery, F. A. Schmitt, R. J. Kryscio, D. G. Davis, C. D. Smith, and D. R. Wekstein, “Neuropathologic substrate of mild cognitive impairment,” Archives of Neurology, vol. 63, no. 1, pp. 38–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. C. W. Cotman and E. Head, “The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches,” Journal of Alzheimer's Disease, vol. 15, no. 4, pp. 685–707, 2008. View at Google Scholar · View at Scopus
  30. S. B. Martin, A. L. S. Dowling, and E. Head, “Therapeutic interventions targeting β amyloid pathogenesis in an aging dog model,” Current Neuropharmacology, vol. 9, no. 4, pp. 651–661, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. D. M. Walsh, I. Klyubin, J. V. Fadeeva, M. J. Rowan, and D. J. Selkoe, “Amyloid-β oligomers: their production, toxicity and therapeutic inhibition,” Biochemical Society Transactions, vol. 30, no. 4, pp. 552–557, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Kayed, E. Head, J. L. Thompson et al., “Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis,” Science, vol. 300, no. 5618, pp. 486–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. D. J. Selkoe, “Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior,” Behavioural Brain Research, vol. 192, no. 1, pp. 106–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. J. L. Tomic, A. Pensalfini, E. Head, and C. G. Glabe, “Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction,” Neurobiology of Disease, vol. 35, no. 3, pp. 352–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Pop, E. Head, N. C. Berchtold et al., “Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines,” Neurobiology of Aging, vol. 33, no. 1, pp. 108–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Shimada, M. Kuwamura, T. Awakura et al., “Topographic relationship between senile plaques and cerebrovascular amyloidosis in the brain of aged dogs,” The Journal of Veterinary Medical Science, vol. 54, no. 1, pp. 137–144, 1992. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Uchida, Y. Miyauchi, H. Nakayama, and N. Goto, “Amyloid angiopathy with cerebral hemorrhage and senile plaque in aged dogs,” Nippon Juigaku Zasshi, vol. 52, no. 3, pp. 605–611, 1990. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Uchida, H. Nakayama, and N. Goto, “Pathological studies on cerebral amyloid angiopathy, senile plaques and amyloid deposition in visceral organs in aged dogs,” The Journal of Veterinary Medical Science, vol. 53, no. 6, pp. 1037–1042, 1991. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Uchida, H. Nakayama, S. Tateyama, and N. Goto, “Immunohistochemical analysis of constituents of senile plaques and cerebro-vascular amyloid in aged dogs,” The Journal of Veterinary Medical Science, vol. 54, no. 5, pp. 1023–1029, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Uchida, K. Kuroki, T. Yoshino, R. Yamaguchi, and S. Tateyama, “Immunohistochemical study of constituents other than β-protein in canine senile plaques and cerebral amyloid angiopathy,” Acta Neuropathologica, vol. 93, no. 3, pp. 277–284, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Yoshino, K. Uchida, S. Tateyama, R. Yamaguchi, H. Nakayama, and N. Goto, “A retrospective study of canine senile plaques and cerebral amyloid angiopathy,” Veterinary Pathology, vol. 33, no. 2, pp. 230–234, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Attems, K. A. Jellinger, and F. Lintner, “Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy,” Acta Neuropathologica, vol. 110, no. 3, pp. 222–231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. R. J. Ellis, J. M. Olichney, L. J. Thal et al., “Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, part XV,” Neurology, vol. 46, no. 6, pp. 1592–1596, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. A. A. M. Rensink, R. M. W. de Waal, B. Kremer, and M. M. Verbeek, “Pathogenesis of cerebral amyloid angiopathy,” Brain Research Reviews, vol. 43, no. 2, pp. 207–223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. J. A. R. Nicoll, M. Yamada, J. Frackowiak, B. Mazur-Kolecka, and R. O. Weller, “Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease: Pro-CAA position statement,” Neurobiology of Aging, vol. 25, no. 5, pp. 589–597, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Attems, “Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms,” Acta Neuropathologica, vol. 110, no. 4, pp. 345–359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Firla̧g, M. Kamaszewski, K. Gaca, and B. Bałasińska, “Age-related changes in the central nervous system in selected domestic mammals and primates,” Postepy Higieny y Medycyny Doswiadczalnej, vol. 67, pp. 269–275, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. B. J. Cummings, E. Head, W. Ruehl, N. W. Milgram, and C. W. Cotman, “The canine as an animal model of human aging and dementia,” Neurobiology of Aging, vol. 17, no. 2, pp. 259–268, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Axelsson, A. Ratnakumar, M.-L. Arendt et al., “The genomic signature of dog domestication reveals adaptation to a starch-rich diet,” Nature, vol. 495, no. 7441, pp. 360–364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. D. A. Blizard, L. C. Klein, R. Cohen, and G. E. McClearn, “A novel mouse-friendly cognitive task suitable for use in aging studies,” Behavior Genetics, vol. 33, no. 2, pp. 181–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. R. J. Gerson, J. S. Macdonald, A. W. Alberts et al., “Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme a reductase inhibitors,” The American Journal of Medicine, vol. 87, supplement 4, pp. S28–S38, 1989. View at Google Scholar · View at Scopus
  52. A. W. Alberts, “Lovastatin and simvastatin—inhibitors of HMGCoA reductase and cholesterol biosynthesis,” Cardiology, vol. 77, no. 4, pp. 14–21, 1990. View at Google Scholar · View at Scopus
  53. D. A. Butterfield, “β-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease,” Chemical Research in Toxicology, vol. 10, no. 5, pp. 495–506, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. D. A. Butterfield, J. Drake, C. Pocernich, and A. Castegna, “Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide,” Trends in Molecular Medicine, vol. 7, no. 12, pp. 548–554, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. D. A. Butterfield, T. Reed, S. F. Newman, and R. Sultana, “Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment,” Free Radical Biology & Medicine, vol. 43, no. 5, pp. 658–677, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. K. Shigenaga, T. M. Hagen, and B. N. Ames, “Oxidative damage and mitochondrial decay in aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 23, pp. 10771–10778, 1994. View at Publisher · View at Google Scholar · View at Scopus
  57. K. A. Jellinger, “Recent advances in our understanding of neurodegeneration,” Journal of Neural Transmission, vol. 116, no. 9, pp. 1111–1162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. V. N. Uversky, “Intrinsic disorder in proteins associated with neurodegenerative diseases,” Frontiers in Bioscience, vol. 14, no. 14, pp. 5188–5238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. R. K. Leak, “Heat shock proteins in neurodegenerative disorders and aging,” Journal of Cell Communication and Signaling, vol. 8, no. 4, pp. 293–310, 2014. View at Publisher · View at Google Scholar
  60. C. M. Dobson, “Protein folding and misfolding,” Nature, vol. 426, no. 6968, pp. 884–890, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. P. J. Muchowski and J. L. Wacker, “Modulation of neurodegeneration by molecular chaperones,” Nature Reviews Neuroscience, vol. 6, no. 1, pp. 11–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. C. A. Ross and M. A. Poirier, “Protein aggregation and neurodegenerative disease,” Nature Medicine, vol. 10, supplement, pp. S10–S17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Shang and A. Taylor, “Ubiquitin-proteasome pathway and cellular responses to oxidative stress,” Free Radical Biology & Medicine, vol. 51, no. 1, pp. 5–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. K. D. Salway, E. J. Gallagher, M. M. Page, and J. A. Stuart, “Higher levels of heat shock proteins in longer-lived mammals and birds,” Mechanisms of Ageing and Development, vol. 132, no. 6-7, pp. 287–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. A. L. Goldberg, “Protein degradation and protection against misfolded or damaged proteins,” Nature, vol. 426, no. 6968, pp. 895–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. S. H. Lecker, A. L. Goldberg, and W. E. Mitch, “Protein degradation by the ubiquitin-proteasome pathway in normal and disease states,” Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 1807–1819, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Arias and A. M. Cuervo, “Chaperone-mediated autophagy in protein quality control,” Current Opinion in Cell Biology, vol. 23, no. 2, pp. 184–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. E. T.-L. Soo, Y.-K. Ng, B.-H. Bay, and G. W.-C. Yip, “Heat shock proteins and neurodegenerative disorders,” TheScientificWorldJOURNAL, vol. 8, pp. 270–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, “Autophagy fights disease through cellular self-digestion,” Nature, vol. 451, no. 7182, pp. 1069–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. J. N. Keller, J. Gee, and Q. Ding, “The proteasome in brain aging,” Ageing Research Reviews, vol. 1, no. 2, pp. 279–293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. Q. Ding and J. N. Keller, “Proteasomes and proteasome inhibition in the central nervous system,” Free Radical Biology and Medicine, vol. 31, no. 5, pp. 574–584, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Tower, “Hsps and aging,” Trends in Endocrinology and Metabolism, vol. 20, no. 5, pp. 216–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. S. K. Calderwood, A. Murshid, and T. Prince, “The shock of aging: molecular chaperones and the heat shock response in longevity and aging—a mini-review,” Gerontology, vol. 55, no. 5, pp. 550–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. E. Head, J. Liu, T. M. Hagen et al., “Oxidative damage increases with age in a canine model of human brain aging,” Journal of Neurochemistry, vol. 82, no. 2, pp. 375–381, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Skoumalova, J. Rofina, Z. Schwippelova, E. Gruys, and J. Wilhelm, “The role of free radicals in canine counterpart of senile dementia of the Alzheimer type,” Experimental Gerontology, vol. 38, no. 6, pp. 711–719, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Papaioannou, P. C. J. Tooten, A. M. Van Ederen et al., “Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques,” Amyloid, vol. 8, no. 1, pp. 11–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. J. E. Rofina, K. Singh, A. Skoumalova-Vesela et al., “Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine,” Amyloid, vol. 11, no. 2, pp. 90–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. J. E. Rofina, A. M. van Ederen, M. J. M. Toussaint et al., “Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease,” Brain Research, vol. 1069, no. 1, pp. 216–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. I. K. Hwang, Y. S. Yoon, K.-Y. Yoo et al., “Differences in lipid peroxidation and Cu, Zn-superoxide dismutase in the hippocampal CA1 region between adult and aged dogs,” Journal of Veterinary Medical Science, vol. 70, no. 3, pp. 273–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. W. Kiatipattanasakul, S.-I. Nakamura, K. Kuroki, H. Nakayama, and K. Doi, “Immunohistochemical detection of anti-oxidative stress enzymes in the dog brain,” Neuropathology, vol. 17, no. 4, pp. 307–312, 1997. View at Publisher · View at Google Scholar · View at Scopus
  81. W. O. Opii, G. Joshi, E. Head et al., “Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease,” Neurobiology of Aging, vol. 29, no. 1, pp. 51–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. C. D. Smith, J. M. Carney, P. E. Starke-Reed et al., “Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 23, pp. 10540–10543, 1991. View at Publisher · View at Google Scholar · View at Scopus
  83. B. N. Ames, M. K. Shigenaga, and T. M. Hagen, “Oxidants, antioxidants, and the degenerative diseases of aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 7915–7922, 1993. View at Publisher · View at Google Scholar · View at Scopus
  84. M. A. Smith, L. M. Sayre, V. M. Monnier, and G. Perry, “Oxidative posttranslational modifications in Alzheimer’s disease,” Molecular and Chemical Neuropathology, vol. 28, no. 1–3, pp. 41–48, 1996. View at Publisher · View at Google Scholar · View at Scopus
  85. M. A. Smith, C. A. Rottkamp, A. Nunomura, A. K. Raina, and G. Perry, “Oxidative stress in Alzheimer's disease,” Biochimica et Biophysica Acta, vol. 1502, no. 1, pp. 139–144, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. M. A. Lovell, S. P. Gabbita, and W. R. Markesbery, “Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF,” Journal of Neurochemistry, vol. 72, no. 2, pp. 771–776, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. T. J. Montine, M. D. Neely, J. F. Quinn et al., “Lipid peroxidation in aging brain and Alzheimer's disease,” Free Radical Biology & Medicine, vol. 33, no. 5, pp. 620–626, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. D. Praticò, C. M. Clark, F. Liun, V. Y.-M. Lee, and J. Q. Trojanowski, “Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease,” Archives of Neurology, vol. 59, no. 6, pp. 972–976, 2002. View at Google Scholar · View at Scopus
  89. P. Ghi, F. Di Brisco, D. Dallorto, M. C. Osella, and M. Orsetti, “Age-related modifications of egr1 expression and ubiquitin-proteasome components in pet dog hippocampus,” Mechanisms of Ageing and Development, vol. 130, no. 5, pp. 320–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. I. Ferrer, M. P. R. Rivera, M. Pumarola et al., “Primary central white matter degeneration in old dogs,” Acta Neuropathologica, vol. 86, no. 2, pp. 172–175, 1993. View at Publisher · View at Google Scholar · View at Scopus
  91. K. J. O'Donovan, W. G. Tourtellotte, J. Milbrandt, and J. M. Baraban, “The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience,” Trends in Neurosciences, vol. 22, no. 4, pp. 167–173, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. A. B. James, A.-M. Conway, and B. J. Morris, “Regulation of the neuronal proteasome by Zif268 (Egr1),” Journal of Neuroscience, vol. 26, no. 5, pp. 1624–1634, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. A. B. James, A.-M. Conway, and B. J. Morris, “Genomic profiling of the neuronal target genes of the plasticity-related transcription factor—Zif268,” Journal of Neurochemistry, vol. 95, no. 3, pp. 796–810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Jiang, C. A. Ballinger, Y. Wu et al., “CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation,” Journal of Biological Chemistry, vol. 276, no. 46, pp. 42938–42944, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Murata, T. Chiba, and K. Tanaka, “CHIP: a quality-control E3 ligase collaborating with molecular chaperones,” International Journal of Biochemistry & Cell Biology, vol. 35, no. 5, pp. 572–578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. J.-N. Min, R. A. Whaley, N. E. Sharpless, P. Lockyer, A. L. Portbury, and C. Patterson, “CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control,” Molecular and Cellular Biology, vol. 28, no. 12, pp. 4018–4025, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Dasuri, L. Zhang, P. Ebenezer, Y. Liu, S. O. Fernandez-Kim, and J. N. Keller, “Aging and dietary restriction alter proteasome biogenesis and composition in the brain and liver,” Mechanisms of Ageing and Development, vol. 130, no. 11-12, pp. 777–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. C.-H. Yu, G.-S. Song, J.-Y. Yhee et al., “Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer’s disease and the brain of aged dogs with cognitive dysfunction,” Journal of Comparative Pathology, vol. 145, no. 1, pp. 45–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. K. Kuroki, K. Uchida, W. Kiatipattanasakul et al., “Immunohistochemical detection of tau protein in various non-human animal brains,” Neuropathology, vol. 17, no. 3, pp. 174–180, 1997. View at Publisher · View at Google Scholar · View at Scopus
  100. J. Wegiel, H. M. Wisniewski, and Z. Soltysiak, “Region- and cell-type-specific pattern of tau phosphorylation in dog brain,” Brain Research, vol. 802, no. 1-2, pp. 259–266, 1998. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Pugliese, J. Mascort, N. Mahy, and I. Ferrer, “Diffuse β-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits,” Acta Neuropathologica, vol. 112, no. 2, pp. 175–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. R. Layfield, J. Lowe, and L. Bedford, “The ubiquitin-proteasome system and neurodegenerative disorders,” Essays in Biochemistry, vol. 41, pp. 157–171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. S. C. Upadhya and A. N. Hegde, “Role of the ubiquitin proteasome system in Alzheimer's disease,” BMC Biochemistry, vol. 8, supplement 1, article S12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. H. Nakayama, K. Uchida, and K. Doi, “A comparative study of age-related brain pathology—are neurodegenerative diseases present in nonhuman animals?” Medical Hypotheses, vol. 63, no. 2, pp. 198–202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. C. W. Cotman, E. Head, B. A. Muggenburg, S. Zicker, and N. W. Milgram, “Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction,” Neurobiology of Aging, vol. 23, no. 5, pp. 809–818, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. N. W. Milgram, E. Head, B. Muggenburg et al., “Landmark discrimination learning in the dog: effects of age, an antioxidant fortified food, and cognitive strategy,” Neuroscience & Biobehavioral Reviews, vol. 26, no. 6, pp. 679–695, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. V. Pop, E. Head, M.-A. Hill et al., “Synergistic effects of long-term antioxidant diet and behavioral enrichment on β-amyloid load and non-amyloidogenic processing in aged canines,” The Journal of Neuroscience, vol. 30, no. 29, pp. 9831–9839, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Fahnestock, M. Marchese, E. Head et al., “BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog,” Neurobiology of Aging, vol. 33, no. 3, pp. 546–554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  109. D. A. Butterfield, E. Barone, F. Di Domenico et al., “Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain,” International Journal of Neuropsychopharmacology, vol. 15, no. 7, pp. 981–987, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. H. M. Schipper, “Heme oxygenase-1: role in brain aging and neurodegeneration,” Experimental Gerontology, vol. 35, no. 6-7, pp. 821–830, 2000. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Jazwa and A. Cuadrado, “Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases,” Current Drug Targets, vol. 11, no. 12, pp. 1517–1531, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. M. Zhang, C. An, Y. Gao, R. K. Leak, J. Chen, and F. Zhang, “Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection,” Progress in Neurobiology, vol. 100, no. 1, pp. 30–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. B. Kalmar and L. Greensmith, “Induction of heat shock proteins for protection against oxidative stress,” Advanced Drug Delivery Reviews, vol. 61, no. 4, pp. 310–318, 2009. View at Publisher · View at Google Scholar · View at Scopus